author_facet Zhang, Li
MacIsaac, Kenzie D.
Zhou, Ting
Huang, Pei-Yu
Xin, Chunlin
Dobson, Jason R.
Yu, Kun
Chiang, Derek Y.
Fan, Yue
Pelletier, Marc
Wang, Yan
Jaeger, Savina
Krishnamurthy Radhakrishnan, Viveksagar
JeBailey, Lellean
Skewes-Cox, Peter
Zhang, Jing
Fang, Wenfeng
Huang, Yan
Zhao, Hongyun
Zhao, Yuanyuan
Li, En
Peng, Bin
Huang, Alan
Dranoff, Glenn
Hammerman, Peter S.
Engelman, Jeffrey
Bitter, Hans
Zeng, Yi-Xin
Yao, Yao
Zhang, Li
MacIsaac, Kenzie D.
Zhou, Ting
Huang, Pei-Yu
Xin, Chunlin
Dobson, Jason R.
Yu, Kun
Chiang, Derek Y.
Fan, Yue
Pelletier, Marc
Wang, Yan
Jaeger, Savina
Krishnamurthy Radhakrishnan, Viveksagar
JeBailey, Lellean
Skewes-Cox, Peter
Zhang, Jing
Fang, Wenfeng
Huang, Yan
Zhao, Hongyun
Zhao, Yuanyuan
Li, En
Peng, Bin
Huang, Alan
Dranoff, Glenn
Hammerman, Peter S.
Engelman, Jeffrey
Bitter, Hans
Zeng, Yi-Xin
Yao, Yao
author Zhang, Li
MacIsaac, Kenzie D.
Zhou, Ting
Huang, Pei-Yu
Xin, Chunlin
Dobson, Jason R.
Yu, Kun
Chiang, Derek Y.
Fan, Yue
Pelletier, Marc
Wang, Yan
Jaeger, Savina
Krishnamurthy Radhakrishnan, Viveksagar
JeBailey, Lellean
Skewes-Cox, Peter
Zhang, Jing
Fang, Wenfeng
Huang, Yan
Zhao, Hongyun
Zhao, Yuanyuan
Li, En
Peng, Bin
Huang, Alan
Dranoff, Glenn
Hammerman, Peter S.
Engelman, Jeffrey
Bitter, Hans
Zeng, Yi-Xin
Yao, Yao
spellingShingle Zhang, Li
MacIsaac, Kenzie D.
Zhou, Ting
Huang, Pei-Yu
Xin, Chunlin
Dobson, Jason R.
Yu, Kun
Chiang, Derek Y.
Fan, Yue
Pelletier, Marc
Wang, Yan
Jaeger, Savina
Krishnamurthy Radhakrishnan, Viveksagar
JeBailey, Lellean
Skewes-Cox, Peter
Zhang, Jing
Fang, Wenfeng
Huang, Yan
Zhao, Hongyun
Zhao, Yuanyuan
Li, En
Peng, Bin
Huang, Alan
Dranoff, Glenn
Hammerman, Peter S.
Engelman, Jeffrey
Bitter, Hans
Zeng, Yi-Xin
Yao, Yao
Molecular Cancer Research
Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
Cancer Research
Oncology
Molecular Biology
author_sort zhang, li
spelling Zhang, Li MacIsaac, Kenzie D. Zhou, Ting Huang, Pei-Yu Xin, Chunlin Dobson, Jason R. Yu, Kun Chiang, Derek Y. Fan, Yue Pelletier, Marc Wang, Yan Jaeger, Savina Krishnamurthy Radhakrishnan, Viveksagar JeBailey, Lellean Skewes-Cox, Peter Zhang, Jing Fang, Wenfeng Huang, Yan Zhao, Hongyun Zhao, Yuanyuan Li, En Peng, Bin Huang, Alan Dranoff, Glenn Hammerman, Peter S. Engelman, Jeffrey Bitter, Hans Zeng, Yi-Xin Yao, Yao 1541-7786 1557-3125 American Association for Cancer Research (AACR) Cancer Research Oncology Molecular Biology http://dx.doi.org/10.1158/1541-7786.mcr-17-0134 <jats:title>Abstract</jats:title> <jats:p>Nasopharyngeal carcinoma (NPC) is an Epstein–Barr virus (EBV) associated cancer characterized by a poor prognosis and a high level of lymphocyte infiltrate. Genetic hallmarks of NPC are not completely known but include deletion of the p16 (CDKN2A) locus and mutations in NF-κB pathway components, with a relatively low total mutational load. To better understand the genetic landscape, an integrated genomic analysis was performed using a large clinical cohort of treatment-naïve NPC tumor specimens. This genomic analysis was generally concordant with previous studies; however, three subtypes of NPC were identified by differences in immune cell gene expression, prognosis, tumor cell morphology, and genetic characteristics. A gene expression signature of proliferation was poorly prognostic and associated with either higher mutation load or specific EBV gene expression patterns in a subtype-specific manner. Finally, higher levels of stromal tumor-infiltrating lymphocytes associated with good prognosis and lower expression of a WNT and TGFβ pathway activation signature.</jats:p> <jats:p>Implications: This study represents the first integrated analysis of mutation, copy number, and gene expression data in NPC and suggests how tumor genetics and EBV infection influence the tumor microenvironment in this disease. These insights should be considered for guiding immunotherapy treatment strategies in this disease. Mol Cancer Res; 15(12); 1722–32. ©2017 AACR.</jats:p> Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes Molecular Cancer Research
doi_str_mv 10.1158/1541-7786.mcr-17-0134
facet_avail Online
Free
finc_class_facet Medizin
Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xNTQxLTc3ODYubWNyLTE3LTAxMzQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xNTQxLTc3ODYubWNyLTE3LTAxMzQ
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
imprint American Association for Cancer Research (AACR), 2017
imprint_str_mv American Association for Cancer Research (AACR), 2017
issn 1541-7786
1557-3125
issn_str_mv 1541-7786
1557-3125
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str zhang2017genomicanalysisofnasopharyngealcarcinomarevealstmebasedsubtypes
publishDateSort 2017
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Molecular Cancer Research
source_id 49
title Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_unstemmed Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_full Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_fullStr Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_full_unstemmed Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_short Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_sort genomic analysis of nasopharyngeal carcinoma reveals tme-based subtypes
topic Cancer Research
Oncology
Molecular Biology
url http://dx.doi.org/10.1158/1541-7786.mcr-17-0134
publishDate 2017
physical 1722-1732
description <jats:title>Abstract</jats:title> <jats:p>Nasopharyngeal carcinoma (NPC) is an Epstein–Barr virus (EBV) associated cancer characterized by a poor prognosis and a high level of lymphocyte infiltrate. Genetic hallmarks of NPC are not completely known but include deletion of the p16 (CDKN2A) locus and mutations in NF-κB pathway components, with a relatively low total mutational load. To better understand the genetic landscape, an integrated genomic analysis was performed using a large clinical cohort of treatment-naïve NPC tumor specimens. This genomic analysis was generally concordant with previous studies; however, three subtypes of NPC were identified by differences in immune cell gene expression, prognosis, tumor cell morphology, and genetic characteristics. A gene expression signature of proliferation was poorly prognostic and associated with either higher mutation load or specific EBV gene expression patterns in a subtype-specific manner. Finally, higher levels of stromal tumor-infiltrating lymphocytes associated with good prognosis and lower expression of a WNT and TGFβ pathway activation signature.</jats:p> <jats:p>Implications: This study represents the first integrated analysis of mutation, copy number, and gene expression data in NPC and suggests how tumor genetics and EBV infection influence the tumor microenvironment in this disease. These insights should be considered for guiding immunotherapy treatment strategies in this disease. Mol Cancer Res; 15(12); 1722–32. ©2017 AACR.</jats:p>
container_issue 12
container_start_page 1722
container_title Molecular Cancer Research
container_volume 15
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348596145750026
geogr_code not assigned
last_indexed 2024-03-01T18:13:29.38Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Genomic+Analysis+of+Nasopharyngeal+Carcinoma+Reveals+TME-Based+Subtypes&rft.date=2017-12-01&genre=article&issn=1557-3125&volume=15&issue=12&spage=1722&epage=1732&pages=1722-1732&jtitle=Molecular+Cancer+Research&atitle=Genomic+Analysis+of+Nasopharyngeal+Carcinoma+Reveals+TME-Based+Subtypes&aulast=Yao&aufirst=Yao&rft_id=info%3Adoi%2F10.1158%2F1541-7786.mcr-17-0134&rft.language%5B0%5D=eng
SOLR
_version_ 1792348596145750026
author Zhang, Li, MacIsaac, Kenzie D., Zhou, Ting, Huang, Pei-Yu, Xin, Chunlin, Dobson, Jason R., Yu, Kun, Chiang, Derek Y., Fan, Yue, Pelletier, Marc, Wang, Yan, Jaeger, Savina, Krishnamurthy Radhakrishnan, Viveksagar, JeBailey, Lellean, Skewes-Cox, Peter, Zhang, Jing, Fang, Wenfeng, Huang, Yan, Zhao, Hongyun, Zhao, Yuanyuan, Li, En, Peng, Bin, Huang, Alan, Dranoff, Glenn, Hammerman, Peter S., Engelman, Jeffrey, Bitter, Hans, Zeng, Yi-Xin, Yao, Yao
author_facet Zhang, Li, MacIsaac, Kenzie D., Zhou, Ting, Huang, Pei-Yu, Xin, Chunlin, Dobson, Jason R., Yu, Kun, Chiang, Derek Y., Fan, Yue, Pelletier, Marc, Wang, Yan, Jaeger, Savina, Krishnamurthy Radhakrishnan, Viveksagar, JeBailey, Lellean, Skewes-Cox, Peter, Zhang, Jing, Fang, Wenfeng, Huang, Yan, Zhao, Hongyun, Zhao, Yuanyuan, Li, En, Peng, Bin, Huang, Alan, Dranoff, Glenn, Hammerman, Peter S., Engelman, Jeffrey, Bitter, Hans, Zeng, Yi-Xin, Yao, Yao, Zhang, Li, MacIsaac, Kenzie D., Zhou, Ting, Huang, Pei-Yu, Xin, Chunlin, Dobson, Jason R., Yu, Kun, Chiang, Derek Y., Fan, Yue, Pelletier, Marc, Wang, Yan, Jaeger, Savina, Krishnamurthy Radhakrishnan, Viveksagar, JeBailey, Lellean, Skewes-Cox, Peter, Zhang, Jing, Fang, Wenfeng, Huang, Yan, Zhao, Hongyun, Zhao, Yuanyuan, Li, En, Peng, Bin, Huang, Alan, Dranoff, Glenn, Hammerman, Peter S., Engelman, Jeffrey, Bitter, Hans, Zeng, Yi-Xin, Yao, Yao
author_sort zhang, li
container_issue 12
container_start_page 1722
container_title Molecular Cancer Research
container_volume 15
description <jats:title>Abstract</jats:title> <jats:p>Nasopharyngeal carcinoma (NPC) is an Epstein–Barr virus (EBV) associated cancer characterized by a poor prognosis and a high level of lymphocyte infiltrate. Genetic hallmarks of NPC are not completely known but include deletion of the p16 (CDKN2A) locus and mutations in NF-κB pathway components, with a relatively low total mutational load. To better understand the genetic landscape, an integrated genomic analysis was performed using a large clinical cohort of treatment-naïve NPC tumor specimens. This genomic analysis was generally concordant with previous studies; however, three subtypes of NPC were identified by differences in immune cell gene expression, prognosis, tumor cell morphology, and genetic characteristics. A gene expression signature of proliferation was poorly prognostic and associated with either higher mutation load or specific EBV gene expression patterns in a subtype-specific manner. Finally, higher levels of stromal tumor-infiltrating lymphocytes associated with good prognosis and lower expression of a WNT and TGFβ pathway activation signature.</jats:p> <jats:p>Implications: This study represents the first integrated analysis of mutation, copy number, and gene expression data in NPC and suggests how tumor genetics and EBV infection influence the tumor microenvironment in this disease. These insights should be considered for guiding immunotherapy treatment strategies in this disease. Mol Cancer Res; 15(12); 1722–32. ©2017 AACR.</jats:p>
doi_str_mv 10.1158/1541-7786.mcr-17-0134
facet_avail Online, Free
finc_class_facet Medizin, Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xNTQxLTc3ODYubWNyLTE3LTAxMzQ
imprint American Association for Cancer Research (AACR), 2017
imprint_str_mv American Association for Cancer Research (AACR), 2017
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2
issn 1541-7786, 1557-3125
issn_str_mv 1541-7786, 1557-3125
language English
last_indexed 2024-03-01T18:13:29.38Z
match_str zhang2017genomicanalysisofnasopharyngealcarcinomarevealstmebasedsubtypes
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 1722-1732
publishDate 2017
publishDateSort 2017
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Molecular Cancer Research
source_id 49
spelling Zhang, Li MacIsaac, Kenzie D. Zhou, Ting Huang, Pei-Yu Xin, Chunlin Dobson, Jason R. Yu, Kun Chiang, Derek Y. Fan, Yue Pelletier, Marc Wang, Yan Jaeger, Savina Krishnamurthy Radhakrishnan, Viveksagar JeBailey, Lellean Skewes-Cox, Peter Zhang, Jing Fang, Wenfeng Huang, Yan Zhao, Hongyun Zhao, Yuanyuan Li, En Peng, Bin Huang, Alan Dranoff, Glenn Hammerman, Peter S. Engelman, Jeffrey Bitter, Hans Zeng, Yi-Xin Yao, Yao 1541-7786 1557-3125 American Association for Cancer Research (AACR) Cancer Research Oncology Molecular Biology http://dx.doi.org/10.1158/1541-7786.mcr-17-0134 <jats:title>Abstract</jats:title> <jats:p>Nasopharyngeal carcinoma (NPC) is an Epstein–Barr virus (EBV) associated cancer characterized by a poor prognosis and a high level of lymphocyte infiltrate. Genetic hallmarks of NPC are not completely known but include deletion of the p16 (CDKN2A) locus and mutations in NF-κB pathway components, with a relatively low total mutational load. To better understand the genetic landscape, an integrated genomic analysis was performed using a large clinical cohort of treatment-naïve NPC tumor specimens. This genomic analysis was generally concordant with previous studies; however, three subtypes of NPC were identified by differences in immune cell gene expression, prognosis, tumor cell morphology, and genetic characteristics. A gene expression signature of proliferation was poorly prognostic and associated with either higher mutation load or specific EBV gene expression patterns in a subtype-specific manner. Finally, higher levels of stromal tumor-infiltrating lymphocytes associated with good prognosis and lower expression of a WNT and TGFβ pathway activation signature.</jats:p> <jats:p>Implications: This study represents the first integrated analysis of mutation, copy number, and gene expression data in NPC and suggests how tumor genetics and EBV infection influence the tumor microenvironment in this disease. These insights should be considered for guiding immunotherapy treatment strategies in this disease. Mol Cancer Res; 15(12); 1722–32. ©2017 AACR.</jats:p> Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes Molecular Cancer Research
spellingShingle Zhang, Li, MacIsaac, Kenzie D., Zhou, Ting, Huang, Pei-Yu, Xin, Chunlin, Dobson, Jason R., Yu, Kun, Chiang, Derek Y., Fan, Yue, Pelletier, Marc, Wang, Yan, Jaeger, Savina, Krishnamurthy Radhakrishnan, Viveksagar, JeBailey, Lellean, Skewes-Cox, Peter, Zhang, Jing, Fang, Wenfeng, Huang, Yan, Zhao, Hongyun, Zhao, Yuanyuan, Li, En, Peng, Bin, Huang, Alan, Dranoff, Glenn, Hammerman, Peter S., Engelman, Jeffrey, Bitter, Hans, Zeng, Yi-Xin, Yao, Yao, Molecular Cancer Research, Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes, Cancer Research, Oncology, Molecular Biology
title Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_full Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_fullStr Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_full_unstemmed Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_short Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
title_sort genomic analysis of nasopharyngeal carcinoma reveals tme-based subtypes
title_unstemmed Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
topic Cancer Research, Oncology, Molecular Biology
url http://dx.doi.org/10.1158/1541-7786.mcr-17-0134